SAN FRANCISCO, Aug. 9, 2026 /PRNewswire/ -- Hagens Berman alerts investors in ADMA Biologics, Inc. (NASDAQ: ADMA) that a securities fraud class action lawsuit has been filed. The lawsuit focuses on alleged misrepresentations concerning the company's financial condition, revenue...
Hence then, the article about deadline next week hagens berman advises adma biologics inc investors to contact the firm before august 10 2026 was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( DEADLINE NEXT WEEK: Hagens Berman Advises ADMA Biologics, Inc. Investors to Contact the Firm Before August 10, 2026 )
Also on site :
- Run! I Spotted Ugg, Tory Burch and Levi's on Sale Before Amazon Prime Big Deal Days
- Hengrui Pharma and Novo Enter Exclusive License Agreement for Once-Weekly Oral GLP-1/GIP Dual Receptor Agonist HRS-1596
- The Biggest Mistake People Make With Fall Mums Can Ruin the Blooms Fast—Here’s What a Gardener Says to Do Instead